Home LiteratureArticle Details
PMID: 13367341 Published · ppublish English Journal Article

Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.

The Journal of experimental medicine ·Vol. 104 ·No. 5 ·1956-11-01 ·Pages 737-62

MCCUNE RM, TOMPSETT R

Abstract

Observations are presented on the behavior of populations of tubercle bacilli in the tissues of mice during the administration of antimicrobial drugs. The behavior of the populations during therapy with any particular drug was different depending upon whether the tubercle bacilli were subsisting in the lung or in the spleen. Moreover, the pattern of microbial behavior was distinctive and predictable for each drug studied. Changes in the size of the populations of tubercle bacilli in the tissues appeared to be a more sensitive reflection of drug influence than microscopic study of the number and character of the tuberculous lesions. Nevertheless, in untreated animals, pulmonary lesions evolved and progressed steadily to a fatal outcome despite the fact that the populations of tubercle bacilli had stabilized at a relatively high census early in the course of therapy. The uniform persistence of tubercle bacilli in the spleen throughout prolonged drug administration was demonstrated with every drug or multiple drug regimens except for pyrazinamide when accompanied by isoniazid. Cultures of the bacilli which survived in the tissues despite antimicrobial therapy were highly susceptible to the drugs employed when tested in vitro. Thus the survival of the tubercle bacilli in the tissues represented microbial persistence rather than drug resistance. When pyrazinamide and isoniazid were administered together, it was not possible to detect the microorganisms in the spleen or lungs of treated animals. A detailed investigation of this apparent abolition of microbial persistence forms the subject of an accompanying report.

Keywords
ISONIAZID/effects NICOTINIC ACID/related compounds PARA-AMINOSALICYLIC ACID/effects STREPTOMYCIN/effects TUBERCULOSIS/experimental
MeSH Terms
Aminosalicylic Acid/pharmacology Animals Anti-Infective Agents Bacillus Drug Resistance, Microbial Gram-Positive Bacteria Isoniazid/pharmacology Lung Mice Mycobacterium tuberculosis Niacin/analogs & derivatives Nicotinic Acids Pyrazinamide Streptomycin/pharmacology Tuberculosis
Chemicals
Anti-Infective Agents Nicotinic Acids Niacin Pyrazinamide Aminosalicylic Acid Isoniazid Streptomycin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
MCCUNE R M
TOMPSETT R
References (5)
5 references, click to expand
  1. Pyrazinamide-isoniazid in tuberculosis.
    Am Rev Tuberc. 1954 Mar;69(3):319-33 PMID: 13138867
  2. The influence of pyrazinamide-isoniazid on M. tuberculosis in animals and man.
    Trans Assoc Am Physicians. 1954;67:224-31 PMID: 13216831
  3. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug.
    J Exp Med. 1956 Nov 1;104(5):763-802 PMID: 13367342
  4. Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis.
    Am Rev Tuberc. 1952 May;65(5):523-46 PMID: 14924175
  5. Nonautomatic pipetting devices for the microbiologic laboratory.
    J Lab Clin Med. 1950 Apr;35(4):648-51 PMID: 15412298
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1956-11-01
Pages
737-62
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2136613
Subset
OM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]